Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carducci

Showing results (121-130 of 452) with videos related to

Pageof 46
Sort By:
Mutagenesis|May 1, 1987
Experimental model for evaluating the effects of genetic and exogenous factors on transplacental mutagenesisR Barale, L Migliore, D Zucconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancerRyan M Franke, Michael A Carducci, Michelle A Rudek, et al.
Analytical Biochemistry|December 24, 2003
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometrySharyn D Baker, Ming Zhao, Ping He, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
Journal of Preventive Medicine and Hygiene|October 26, 2006
Virological investigation on aerosol from waste depuration plantsG Sigari, D Panatto, P Lai, et al.
International Journal of Impotence Research|April 18, 2006
Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapyM Braga-Basaria, D C Muller, M A Carducci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 21, 2021
End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical TrialsRamy Sedhom, Amanda L Blackford, Arjun Gupta, et al.
The Prostate|May 7, 2019
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, et al.
The Prostate|May 5, 2007
Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivoShabana Shabbeer, Madeleine S Q Kortenhorst, Sushant Kachhap, et al.
Journal of Inherited Metabolic Disease|October 14, 2000
Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuriaV Leuzzi, M C Bianchi, M Tosetti, et al.
Pageof 46

Showing results (121-130 of 452) with videos related to

Sort By:
Pageof 46
Mutagenesis|May 1, 1987
Experimental model for evaluating the effects of genetic and exogenous factors on transplacental mutagenesisR Barale, L Migliore, D Zucconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancerRyan M Franke, Michael A Carducci, Michelle A Rudek, et al.
Analytical Biochemistry|December 24, 2003
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometrySharyn D Baker, Ming Zhao, Ping He, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
Journal of Preventive Medicine and Hygiene|October 26, 2006
Virological investigation on aerosol from waste depuration plantsG Sigari, D Panatto, P Lai, et al.
International Journal of Impotence Research|April 18, 2006
Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapyM Braga-Basaria, D C Muller, M A Carducci, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 21, 2021
End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical TrialsRamy Sedhom, Amanda L Blackford, Arjun Gupta, et al.
The Prostate|May 7, 2019
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, et al.
The Prostate|May 5, 2007
Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivoShabana Shabbeer, Madeleine S Q Kortenhorst, Sushant Kachhap, et al.
Journal of Inherited Metabolic Disease|October 14, 2000
Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuriaV Leuzzi, M C Bianchi, M Tosetti, et al.
Pageof 46